Literature DB >> 16876104

Creation of a recombinant peptide substrate for fluorescence resonance energy transfer-based protease assays.

Lin Zhang1, Heather L Lawson, Vallathucherry C Harish, Jason D Huff, Mary Ann Knovich, John Owen.   

Abstract

Mesh：

Substances：

Year:  2006        PMID： 16876104     DOI： 10.1016/j.ab.2006.06.022

Source DB:  PubMed          Journal:  Anal Biochem        ISSN： 0003-2697            Impact factor:   3.365


× No keyword cloud information.
  18 in total

1.  Gain-of-function ADAMTS13 variants that are resistant to autoantibodies against ADAMTS13 in patients with acquired thrombotic thrombocytopenic purpura.

Authors:  Cui Jian; Juan Xiao; Lingjie Gong; Christopher G Skipwith; Sheng-Yu Jin; Hau C Kwaan; X Long Zheng
Journal:  Blood       Date:  2012-01-30       Impact factor: 22.113

2.  Von Willebrand factor antigen and ADAMTS13 activity assay in pregnant women and severe preeclamptic patients.

Authors:  Dandan Zhang; Juan Xiao; Haoliang Huang; Juanjuan Chen; Tao Liu; Zongzhi Yin; Danping Gao; Qiong Liu; Jihui Ai; Suhua Chen
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2010-12-22

3.  Plasma levels of complement activation fragments C3b and sC5b-9 significantly increased in patients with thrombotic microangiopathy after allogeneic stem cell transplantation.

Authors:  Jiaqian Qi; Jie Wang; Jia Chen; Jian Su; Yaqiong Tang; Xiaojin Wu; Xiao Ma; Feng Chen; Changgeng Ruan; X Long Zheng; Depei Wu; Yue Han
Journal:  Ann Hematol       Date:  2017-08-11       Impact factor: 3.673

4.  Unconjugated bilirubin inhibits proteolytic cleavage of von Willebrand factor by ADAMTS13 protease.

Authors:  R-N Lu; S Yang; H M Wu; X L Zheng
Journal:  J Thromb Haemost       Date:  2015-04-23       Impact factor: 5.824

5.  Plasma ADAMTS13 activity and von Willebrand factor antigen and activity in patients with subarachnoid haemorrhage.

Authors:  Monisha Kumar; Wenjing Cao; Jenny K McDaniel; Huy P Pham; Dheeraj Raju; Kelsey Nawalinski; Suzanne Frangos; David Kung; Eric Zager; Scott E Kasner; Joshua M Levine; X Long Zheng
Journal:  Thromb Haemost       Date:  2017-01-19       Impact factor: 5.249

6.  Biochemical characterization of recombinant Enterovirus 71 3C protease with fluorogenic model peptide substrates and development of a biochemical assay.

Authors:  Luqing Shang; Shumei Zhang; Xi Yang; Jixue Sun; Linfeng Li; Zhengjie Cui; Qiuhong He; Yu Guo; Yuna Sun; Zheng Yin
Journal:  Antimicrob Agents Chemother       Date:  2014-11-24       Impact factor: 5.191

7.  A shear-based assay for assessing plasma ADAMTS13 activity and inhibitors in patients with thrombotic thrombocytopenic purpura.

Authors:  Yue Han; Juan Xiao; Erica Falls; X Long Zheng
Journal:  Transfusion       Date:  2011-01-20       Impact factor: 3.157

8.  Transfusion of Platelets Loaded With Recombinant ADAMTS13 (A Disintegrin and Metalloprotease With Thrombospondin Type 1 Repeats-13) Is Efficacious for Inhibiting Arterial Thrombosis Associated With Thrombotic Thrombocytopenic Purpura.

Authors:  Mohammad S Abdelgawwad; Wenjing Cao; Liang Zheng; Nicole K Kocher; Lance A Williams; X Long Zheng
Journal:  Arterioscler Thromb Vasc Biol       Date:  2018-11       Impact factor: 8.311

9.  Human neutrophil peptides inhibit cleavage of von Willebrand factor by ADAMTS13: a potential link of inflammation to TTP.

Authors:  Vikram G Pillai; Jialing Bao; Catherine B Zander; Jenny K McDaniel; Palaniappan S Chetty; Steven H Seeholzer; Khalil Bdeir; Douglas B Cines; X Long Zheng
Journal:  Blood       Date:  2016-05-13       Impact factor: 22.113

10.  Amino acid residues Arg(659), Arg(660), and Tyr(661) in the spacer domain of ADAMTS13 are critical for cleavage of von Willebrand factor.

Authors:  Sheng-Yu Jin; Christopher G Skipwith; X Long Zheng
Journal:  Blood       Date:  2010-01-14       Impact factor: 22.113
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.